Page last updated: 2024-12-05

bromphenol blue

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bromphenol blue is a triphenylmethane dye that is commonly used as a pH indicator. It appears yellow in acidic solutions and blue in basic solutions. It is synthesized through a multi-step process involving the condensation of benzaldehyde and phenol, followed by bromination and sulfonation. Bromphenol blue is often used in biological research as a tracking dye for electrophoresis, a technique used to separate molecules based on their size and charge. Its blue color allows for easy visualization of the migration of molecules in a gel matrix. It is also employed in various analytical chemistry applications, including titrations and spectrophotometry. The compound's ability to change color with pH makes it a useful tool for studying the acidity or alkalinity of solutions. Research on bromphenol blue focuses on its applications in various fields, including analytical chemistry, biochemistry, and molecular biology.'

Bromphenol Blue: A dye that has been used as an industrial dye, a laboratory indicator, and a biological stain. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bromophenol blue : 3H-2,1-Benzoxathiole 1,1-dioxide in which both of the hydrogens at position 3 have been substituted by 3,5-dibromo-4-hydroxyphenyl groups. It is used as a laboratory indicator, changing from yellow below pH 3 to purple at pH 4.6, and as a size marker for monitoring the progress of agarose gel and polyacrylamide gel electrophoresis. It has also been used as an industrial dye. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8272
CHEMBL ID2103765
CHEBI ID59424
SCHEMBL ID19631
MeSH IDM0002958

Synonyms (84)

Synonym
AC-12376
c19h10br4o5s
phenol,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-, s,s-dioxide
bromphenol blue
nsc-7818
albutest
bromophenol blue
115-39-9
3',5',5''-tetrabromophenolsulfonephthalein
nsc7818
tetrabromphenol blue
3,5,5'-tetrabromophenolsulfonphthalein
3',3'',5',5''-tetrabromophenolsulfonephthalein
brn 0061698
3',3'',5',5''-tetrabromophenolsulfophthalein
nsc 7818
3,3',5,5'-tetrabromophenolsulfonphthalein
ccris 5487
einecs 204-086-2
phenol, 4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromo-, s,s-dioxide
ai3-52697
phenol, 4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-
2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-phenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]phenol
bromophenol blue, acs reagent
B0631
B0118
4,4'-(1,1-dioxido-3h-2,1-benzoxathiole-3,3-diyl)bis(2,6-dibromophenol)
CHEBI:59424 ,
bromophenol blue, sultone form
AKOS000813838
2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxyphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]phenol
A803432
4-[3-[3,5-bis(bromanyl)-4-oxidanyl-phenyl]-1,1-bis(oxidanylidene)-2,1$l^{6}-benzoxathiol-3-yl]-2,6-bis(bromanyl)phenol
NCGC00255409-01
dtxsid6041682 ,
dtxcid4021682
cas-115-39-9
tox21_302080
brophenol blue
cas_8272
cas_115-39-9
nsc_8272
bdbm85044
CHEMBL2103765
0r2969yc90 ,
5-19-03-00458 (beilstein handbook reference)
unii-0r2969yc90
hsdb 7728
FT-0614001
bromphenol blue sultone form
SCHEMBL19631
bromphenol blue [inci]
bromophenol blue [hsdb]
4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis(2,6-dibromophenol)
bromphenol blue [mi]
J-610052
4,4'-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-phenol]
tetrabromophenolsulfonphthalein
phenol, 4,4'-(3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-, s,s-dioxide
bromophenol blue indicator
mfcd00005875
albutest;nsc 7818; tetrabromophenolsulfophthalein
STL453501
bromophenol blue, jis special grade
bromophenol blue, electrophoresis grade
bromophenol blue acs grade
bromophenol blue, acs reagent, ep
3,3-bis(3,5-dibromo-4-hydroxyphenyl)-3h-benzo[c][1,2]oxathiole 1,1-dioxide
4,4-(1,1-dioxido-3h-2,1-benzoxathiol-3-ylidene)bis[2,6-dibromo-phenol]
Q421129
HB0718
bromophenolblue
AMY22379
bromophenol blue (sodium salt)
H10711
2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxyphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]phenol
bromophenol blue solution r2
bromophenol blue solution
CS-0013463
HY-B1571
CS-0169194
HY-W110798
bromophenol blue indicator (3.0-4.6)

Research Excerpts

Overview

Bromphenol blue appears to be a very helpful and safe tool in posterior segment surgery.

ExcerptReferenceRelevance
"Bromphenol blue appears to be a very helpful and safe tool in posterior segment surgery. "( Vitreoretinal surgery using bromphenol blue as a vital stain: evaluation of staining characteristics in humans.
Haritoglou, C; Kampik, A; Neubauer, AS; Priglinger, SG; Schumann, RG; Strauss, R, 2007
)
2.08

Toxicity

ExcerptReferenceRelevance
" Adverse effects on anterior and posterior segments were evaluated by slit lamp biomicroscopy and ophthalmoscopy."( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006
)
0.33
"BPB or LGSF produced no significantly detectable toxic effects on the retina in vivo."( Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
Eibl, K; Freyer, W; Haritoglou, C; Kampik, A; Mankowska, A; May, CA; Rejdak, R; Schuettauf, F; Thaler, S; Zrenner, E, 2006
)
0.33
" We compared the in vitro toxicity of IfCG, BBG, and BPB with ICG on the retinal pigment epithelial cells and retinal ganglion cells at various concentrations to optimize the safe dose and duration of exposure."( Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green.
Balaiya, S; Brar, VS; Chalam, KV; Murthy, RK, 2011
)
0.37
" Infracyanine green, BBG, and BPB were significantly less toxic on the 2 cell lines at exposure times <15 minutes."( Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green.
Balaiya, S; Brar, VS; Chalam, KV; Murthy, RK, 2011
)
0.37
"Newer vital dyes, IfCG, BBG, and BPB, are significantly less toxic on retinal ganglion cells and retinal pigment epithelial cells' cell lines when compared with ICG."( Comparative in vitro safety analysis of dyes for chromovitrectomy: indocyanine green, brilliant blue green, bromophenol blue, and infracyanine green.
Balaiya, S; Brar, VS; Chalam, KV; Murthy, RK, 2011
)
0.37

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic profile of bromophenol blue (I) in the plasma, urine, and bile of beagle dogs was determined after intravenous administration of 5-, 20-, and 30-mg/kg doses."( Dose-dependent pharmacokinetics and hepatobiliary transport of bromophenol blue in the beagle.
Pearlman, RS; Wills, RJ; Yakatan, GJ, 1984
)
0.27

Bioavailability

ExcerptReferenceRelevance
"The influence of the intermediate products of riboflavine photolysis on the absorption of poorly absorbed water-soluble drugs from the rat small intestine has been examined using an in situ recirculation technique."( An anomalous effect of the intermediate products of riboflavine photolysis on the intestinal absorption of poorly absorbed water-solbule drug in rats.
Ghazy, FS; Kimura, T; Muranishi, S; Sezaki, H, 1975
)
0.25
" Their absorption rate from the peritoneal cavity was faster after intraperitoneal administration to the liver surface than that after intraperitoneal administration to the distal small intestine, as shown by the increase in maximum concentration and decrease in mean residence time in plasma."( Absorption of phenol red and bromphenol blue as model drugs from the peritoneal cavity around the liver surface in rats.
Amagishi, H; Nakamura, J; Nishida, K; Sasaki, H, 1995
)
0.58

Dosage Studied

ExcerptRelevanceReference
"A spectrophotometric method is described for the determination of tilidine in its dosage forms (injection, drops, suppositories)."( Spectrophotometric determination of tilidine using bromocresol green and bromophenol blue.
Dobrila, ZS; Ljiljana, S; Ljiljana, Z, 1990
)
0.28
" A selective late dye concentration dependent on the time is described for 3 triphenylmethane dyes namely bromphenol blue, bromcresol green and iodophenol blue after intravenous application in high dosage in malignant inoculated tumors and experimental tumor metastases in the mouse."( [Selective, time dependent accumulation of the triphenylmethane dyes bromphenol blue, bromoresol green and iodophenol blue in mouse tumors].
Graffi, A, 1981
)
0.71
" Conformity to Beer's law enabled the assay of dosage forms of the drug."( Simple spectrophotometric determination of cinnarizine in its dosage forms.
Abdine, H; Belal, F; Zoman, N, 2002
)
0.31
" The proposed methods have been applied successfully for the analysis of the drug in pure form and in its dosage forms."( Extractive spectrophotometric methods for the determination of oxomemazine hydrochloride in bulk and pharmaceutical formulations using bromocresol green, bromocresol purple and bromophenol blue.
El-Didamony, AM, 2005
)
0.33
" The proposed method could be applied to the determination of AM, MM and RM in dosage forms."( Determination of adamantane derivatives in pharmaceutical formulations by using spectrophotometric UV-Vis method.
Dotka, H; Inerowicz, T; JeliƄska, A; Muszalska, I; Rohowska, P; Sobczak, A, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
two-colour indicatorA colour indicator that possesses a different colour on each side of the transition interval.
acid-base indicatorAn acid or base which exhibits a colour change on neutralization by the basic or acidic titrant at or near the equivalence point of a titration.
dyenull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
sultoneAn intramolecular cyclic ester of a hydroxy sulfonic acid, analogous to lactone.
arenesulfonate esterAn organosulfonic ester resulting from the formal condensation of an arenesulfonic acid with the hydroxy group of an alcohol, enol, phenol or heteroarenol.
2,1-benzoxathiole
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
organobromine compoundA compound containing at least one carbon-bromine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency10.31110.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency4.67200.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency5.58560.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency13.74240.000221.22318,912.5098AID1259243; AID1259247; AID743036; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency35.33850.013326.981070.7614AID1346978
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency70.50960.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency23.05320.001022.650876.6163AID1224838; AID1224839; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency28.45800.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency17.86930.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency19.18120.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency5.60080.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency18.58370.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743078; AID743080; AID743091
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency10.04870.001019.414170.9645AID743094
caspase-3Homo sapiens (human)Potency35.33850.013326.981070.7614AID1346978
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency22.29710.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency17.60340.001628.015177.1139AID1224843; AID1224895; AID1259385; AID1259393; AID1259395
activating transcription factor 6Homo sapiens (human)Potency52.37140.143427.612159.8106AID1159516; AID1159519
Histone H2A.xCricetulus griseus (Chinese hamster)Potency25.92630.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency28.61950.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency3.61890.037617.082361.1927AID1259364; AID1259388
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency17.71120.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency17.71120.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency12.53860.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency12.53860.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID80631Percent relaxation of isolated guinea pig trachea.1998Bioorganic & medicinal chemistry letters, Mar-03, Volume: 8, Issue:5
New bronchodilators selected by molecular topology.
AID80624Percent relaxation using isolated guinea pig trachea.1998Bioorganic & medicinal chemistry letters, Mar-03, Volume: 8, Issue:5
New bronchodilators selected by molecular topology.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (245)

TimeframeStudies, This Drug (%)All Drugs %
pre-199096 (39.18)18.7374
1990's31 (12.65)18.2507
2000's63 (25.71)29.6817
2010's36 (14.69)24.3611
2020's19 (7.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.79 (24.57)
Research Supply Index5.59 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index98.81 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (1.88%)6.00%
Case Studies2 (0.75%)4.05%
Observational0 (0.00%)0.25%
Other259 (97.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]